Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Aspen, Bambusa target $135M IPOs; AstraZeneca vs. Takeda in gastric cancer ADCs

Plus news about Hutchmed, Johnson & Johnson, Jazz Pharmaceuticals, Novartis, Roche and Oruka Therapeutics. Aspen, Bambusa both eye $135M IPOs: Aspen Neuroscience plans to sell 9.38 million shares {$ASPE} between $15 ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Monday 26 October →